NCT03443479View on ClinicalTrials.gov

Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure

CompletedOBSERVATIONAL
Enrollment

324

Participants

Timeline

Start Date

April 1, 2015

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Respiratory FailureRespiratory InsufficiencyRespiratory Tract DiseasesCOPDCOPD ExacerbationPneumoniaChronic Obstructive Pulmonary Disease
Interventions
DEVICE

Non-Invasive Ventilation

Treatment with Non-Invasive Ventilation by BiPAP. Different BiPAP models are in use. Ventilation parameters set at the discretion of the treating physician.

DEVICE

High-Flow Nasal Cannula

Treatment with a High-Flow Nasal Cannula. The Optiflow device by Fisher\&Paykel used in all cases. Flow and fraction of inspired oxygen (FiO2) parameters at the discretion of the treating physician.

Trial Locations (1)

H4G2A2

Hôpital de Verdun, Montreal

All Listed Sponsors
lead

Hôpital de Verdun

OTHER

NCT03443479 - Comparison of High-flow Oxygen vs. BiPAP in Type II (Hypercapnic) Respiratory Failure | Biotech Hunter | Biotech Hunter